Literature DB >> 16893655

Predicted versus observed FEV1 in the immediate postoperative period after pulmonary lobectomy.

Gonzalo Varela1, Alessandro Brunelli, Gaetano Rocco, Rita Marasco, Marcelo F Jiménez, Valeria Sciarra, José Luis Aranda, Tindaro Gatani.   

Abstract

OBJECTIVE: Scanty information can be found regarding ppoFEV1% correlation with true FEV1% in the immediate days after surgery, when most cardio-respiratory complications are developed. This prospective multicentric investigation aims to describe the evolution of FEV1 in a series of uneventful lobectomy cases before hospital discharge, and to identify factors associated with the variation of postoperative residual FEV1, with the ratio between the actual and the predicted postoperative FEV1 measured during the first 6 postoperative days.
METHODS: One hundred and sixty-one patients submitted to lobectomy were prospectively enrolled in the study. Patients with chest wall resections and postoperative complications were excluded. Data from a total of 125 patients were thus used for the analysis. The following clinical variables were recorded: age, preoperative FEV1, ppoFEV1, presence of chronic obstructive pulmonary disease (COPD), surgical approach (VATS or muscle-sparing thoracotomy), side (right or left) and site (upper or lower) of resection, type of analgesia (epidural or intravenous), and daily visual analogue pain score (VAS). FEV1 was measured in every patient at hospital admission and daily until discharge or up to postoperative day 6. Random effects time-series cross-sectional regression analyses were performed to identify factors associated with variation of postoperative residual function (100-(preoperative FEV1-postoperative FEV1/preoperative FEV1 x 100)), and of FEV1 ratio ((actual postoperative FEV1 x 100)/ppoFEV1). For these analyses, the dependent variables (postoperative residual function and FEV1 ratio) and the pain score were analysed as panel longitudinal data. The regression analyses were subsequently validated by bootstrap procedure.
RESULTS: FEV1% was lower at first postoperative day and increased gradually up to day 6 but mean values never reached ppoFEV1%. Pain scores decreased from day 1 to day 6. Preoperative FEV1 (p<0.0001) and postoperative pain score (p<0.0001) resulted independently and reliably inversely associated with postoperative residual FEV1 (model R2, 0.16). Preoperative FEV1 (p=0.001), postoperative pain score (p<0.0001), and epidural analgesia (p=0.04) resulted independently and reliably associated with postoperative FEV1 ratio (model R2, 0.13).
CONCLUSION: Current methods of prediction of postoperative FEV1 greatly underestimated the real functional loss in the immediate postoperative period. Therefore, for the purpose of a more accurate risk stratification we need to correct the traditional prediction of postoperative FEV1.

Entities:  

Mesh:

Year:  2006        PMID: 16893655     DOI: 10.1016/j.ejcts.2006.07.001

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  14 in total

1.  [Preoperative evaluation and risk estimation in thoracic surgery].

Authors:  H Mutlak; S Czerner; H Winter; B Zwissler; P Lackermeier
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

2.  Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy.

Authors:  Mark F Berry; Nestor R Villamizar-Ortiz; Betty C Tong; William R Burfeind; David H Harpole; Thomas A D'Amico; Mark W Onaitis
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

3.  Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer.

Authors:  Mark K Ferguson; Sydeaka Watson; Elizabeth Johnson; Wickii T Vigneswaran
Journal:  Eur J Cardiothorac Surg       Date:  2013-09-19       Impact factor: 4.191

4.  Effects of Transcutaneous Electrical Nerve Stimulation on Pain, Pulmonary Function, and Respiratory Muscle Strength After Posterolateral Thoracotomy: A Randomized Controlled Trial.

Authors:  Hermann H Husch; Guilherme Watte; Matheus Zanon; Gabriel Sartori Pacini; Daniella Birriel; Pauline L Carvalho; Adriana Kessler; Graciele Sbruzzi
Journal:  Lung       Date:  2020-02-08       Impact factor: 2.584

5.  Improving family caregiver and patient outcomes in lung cancer surgery: Study protocol for a randomized trial of the multimedia self-management (MSM) intervention.

Authors:  Virginia Sun; Dan J Raz; Loretta Erhunmwunsee; Nora Ruel; Jacqueline Carranza; Rosemary Prieto; Betty Ferrell; Robert S Krouse; Ruth McCorkle; Jae Y Kim
Journal:  Contemp Clin Trials       Date:  2019-07-03       Impact factor: 2.226

Review 6.  Lung cancer in elderly patients.

Authors:  Federico Venuta; Daniele Diso; Ilaria Onorati; Marco Anile; Sara Mantovani; Erino A Rendina
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

7.  Influence of Pulmonary Rehabilitation on Lung Function Changes After the Lung Resection for Primary Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Natasa Mujovic; Nebojsa Mujovic; Dragan Subotic; Maja Ercegovac; Andjela Milovanovic; Ljubica Nikcevic; Vladimir Zugic; Dejan Nikolic
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

8.  Recovery of pulmonary function after lung wedge resection.

Authors:  Shohei Mori; Takamasa Shibazaki; Yuki Noda; Daiki Kato; Takeo Nakada; Hisatoshi Asano; Hideki Matsudaira; Takashi Ohtsuka
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

9.  Measured versus predicted postoperative pulmonary function at repeated times up to 1 year after lobectomy.

Authors:  Takamasa Shibazaki; Shohei Mori; Eriko Harada; Rintaro Shigemori; Daiki Kato; Hideki Matsudaira; Jun Hirano; Takashi Ohtsuka
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29

10.  Lung function in the late postoperative phase and influencing factors in patients undergoing pulmonary lobectomy.

Authors:  Ryoichi Matsumoto; Shinzo Takamori; Shintaro Yokoyama; Toshihiro Hashiguchi; Daigo Murakami; Koichi Yoshiyama; Tatsuya Nishi; Masaki Kashihara; Masahiro Mitsuoka; Ryozo Hayashida; Tatsuyuki Kakuma; Yoshito Akagi
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.